Quidel Corporation
http://www.quidel.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Quidel Corporation
JPM 2021: EY Says Pandemic Leaves Medtech With $500Bn In M&A Firepower
EY’s M&A Firepower report predicts very active M&A activity for medtechs in 2021, driven by diagnostics and digital health, but with some headwinds remaining.
FDA: Rapid Antigen COVID-19 Tests At Risk For False Positives
An alert from the agency warns that the tests, which have become widely used for their speed and portability, carry a risk of false positives.
Coronavirus Antigen Testing Gets Green Light In Germany
Germany is adjusting the national COVID-19 testing strategy, which from mid-October will include the use of antigen tests.
FDA Eager To Authorize More Rapid Antigen COVID-19 Tests
The US FDA’s diagnostics chief says the agency isn’t seeing many submissions for rapid antigen tests, but is eager to authorize them.
Company Information
- Industry
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Cytology
- Molecular Diagnostics & Genetic Testing
- Therapeutic Drug Monitoring
- Other Names / Subsidiaries
-
- AnDiaTec
- BioHelix Corporation
- Diagnostic Hybrids, Inc.